Depression in Parkinson's disease. Assessment and treatment;Depression bei M. Parkinson. Diagnostik und therapie

Nervenarzt

Volumn 78, Issue 6, 2007, Pages 715-728

  Brand, S ^a   Dodel, R ^b   Hautzinger, M ^c   Grunder G ^a   Althaus, A ^b   Schneider, F ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Assessment; Depression; Mood disorders; Parkinson's disease; Treatment

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DIBENZEPIN; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; LOFEPRAMINE; MAPROTILINE; MIANSERIN; MILNACIPRAN; MIRTAZAPINE; MOCLOBEMIDE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; REBOXETINE; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRIMIPRAMINE; UNINDEXED DRUG; VENLAFAXINE; VILOXAZINE;

COPING BEHAVIOR; DEPRESSION; DISEASE ASSOCIATION; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; PARKINSON DISEASE; QUALITY OF LIFE; REVIEW; SEXUAL DYSFUNCTION; SUICIDAL BEHAVIOR;

ADAPTATION, PSYCHOLOGICAL; ANTIDEPRESSIVE AGENTS; COMBINED MODALITY THERAPY; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; HUMANS; MASS SCREENING; PARKINSON DISEASE; PERSONALITY ASSESSMENT; PERSONALITY INVENTORY; PSYCHOTHERAPY; QUALITY OF LIFE; RISK FACTORS; SICK ROLE; SUICIDE;

EID: 34548425588     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-007-2292-2     Document Type: Review

References (29)

1. Bauer M, Whybrow PC, Angst J et al. (2002) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 3: 5-43
2. Bauer M, Whybrow PC, Angst J et al. (2002) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. World J Biol Psychiatry 3: 69-86
3. Benkert O, Hippius R (Hrsg) (2004) Kompendium der psychiatrischen Pharmakotherapie. Springer, Berlin
4. Brand S, Härter M, Sitta P et al. (2005) Datengestützte Qualitätszirkel in der stationären Depressionsbehandlung. Nervenarzt 76: 865-874
5. Campenhausen S von, Bornschein B, Wick R et al. (2005) Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol 15: 473-490
6. Chaudhuri KR, Healy DG, Schapira AH (2006) Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 5: 235-245
7. DeMet EM, Chicz-DeMet A, Fallon JH, Sokolski HN (1999) Sleep deprivation therapy in depressive illness and Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry 23: 753-84
8. Ellgring H, Seiler S, Nagel N et al. (1990) Psychosocial problems of Parkinson patients: approaches to assessment and treatment. In: Streifler MB, Korczyn AD, Melamed E, Youdim MBH (eds) Advances in Neurology: Parkinson's disease: Anatomy, pathology, and treatment. Raven Press, New York, 53, pp 349-353
9. Gibb WR, Lees AJ (1989) The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol 15: 27-44
10. Global Parkinson's Disease Survey Steering Committee (2002) Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord 17: 60-67
11. Goetz CG, Poewe W, Rascol O, Sampaio C (2005) Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Mov Disord 20: 523-539
12. Härter M, Schneider F, Gaebel W, Berger M (Hrsg) (2003) Versorgungsleitlinien für depressive Störungen in der ambulanten Praxis. Supplementband. Z Arztl Fortbild Qualitatssich
13. Härter M, Bermejo I et al. (2004) Rahmenkonzept Integrierte Versorgung Depression der Deutschen Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN)
14. Hautzinger M, Meyer TD(Hrsg) (2002) Diagnostik affektiver Störungen. Kompendium psychologische Diagnostik. Bd. 3. Hogrefe, Göttingen
15. Klein C (2006) Implications of genetics on the diagnosis and care of patients with Parkinson disease. Arch Neurol 63: 328-334
16. Kompetenznetz Depression: www.kompetenznetz-depression.de
17. Kühner C, Weber I (Hrsg) (2001) Depressionen vorbeugen. Ein Gruppenprogramm nach RF Munos. Hogrefe, Göttingen
18. Lemke MR (Hrsg) (2002) Depression und Morbus Parkinson - Klinik, Diagnose, Therapie. Uni-Med Science, Bremen
19. Lemke AR, Ceballos-Baumann AO (2002) Depression bei Parkinson-Patienten. Dtsch Arztebl 99: A2625-A2631; Heft 40
20. Macht M, Schwarz R, Ellgring H (2005) Patterns of psychological problems in Parkinson's disease. Acta Neurol Scand 111: 95-101
21. Macht M, Ellgring H (2003) Psychologische Intervention bei der Parkinson-Erkrankung. Ein Behandlungsmanual. Kohlhammer, Stuttgart
22. McDonald R, DeLong MR (2003) Prevalence, etiology, and treatment of depression in Parkinson's disease. Biol Psychiatry 54: 363-375; Review
23. Moellentine C, Rummans T, Ahlskog JE et al. (1998) Effectiveness of ECT in patients with parkinsonism. J Neuropsychiatry Clin Neurosci 10: 187-193
24. Oertel WH et al. (Hrsg) (2005) Leitlinie M. Parkinson. Thieme, Stuttgart
25. Schneider F, Härter M, Brand S et al. (2005) Guideline adherence of inpatient depression treatment. Br J Psychiatry 187: 462-469
26. Schneider F, Härter M, Kratz S et al. (2003) Unzureichender subjektiver Behandlungsverlauf bei depressiven Patienten in der haus- und nervenärztlichen Praxis. Z Arztl Fortbild Qualitatssich [Suppl IV] 97: 57-66; IF 0,2
27. Schneider F, Kratz S, Bermejo I et al. (2004) Insufficient depression treatment in outpatient settings. German Med Sci 2: Doc1
28. Shabnam GN, Chung TH, Kho D et al. (2003) Therapies for depression in Parkinson's disease. Cochrane database Syst Rev 3: CD003465
29. Wassermann EM, Lisanby SH (2001) Therapeutic application of repetitive transcranial magnetic stimulation: a review. Clin Neurophysiol 112: 1367-1377